BRNS

Barinthus Biotherapeutics plc - ADR

0.76

USD

BRNS Earnings Reports

Positive Surprise Ratio

BRNS beat 12 of 19 last estimates.

63%

Next Report

Date of Next Report

Mar 18, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.40

Implied change from Q3 25 (Revenue/ EPS)

+66.67%

Implied change from Q4 24 (Revenue/ EPS)

-21.57%

Barinthus Biotherapeutics plc - ADR earnings per share and revenue

On Nov 07, 2025, BRNS reported earnings of -0.24 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 47.71% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.08% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an increase of 66.67% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Barinthus Biotherapeutics plc - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Barinthus Biotherapeutics plc - ADR reported EPS of -$0.24, beating estimates by 47.71%, and revenue of $0.00, 0% as expectations.

How did the market react to Barinthus Biotherapeutics plc - ADR's Q3 2025 earnings?

The stock price moved down -10.08%, changed from $1.19 before the earnings release to $1.07 the day after.

When is Barinthus Biotherapeutics plc - ADR expected to report next?

The next earning report is scheduled for Mar 18, 2026.

What are the forecasts for Barinthus Biotherapeutics plc - ADR's next earnings report?

Based on 4 analysts, Barinthus Biotherapeutics plc - ADR is expected to report EPS of -$0.40 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.